Intrinsic value of Argenica Therapeutics Limited (AGN)
Live fair value data for Argenica Therapeutics Limited (AGN) is currently unavailable. Please check again shortly.
Current Price: $104.00
Valuation: Undervalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Argenica Therapeutics Limited (AGN) undervalued or overvalued?
Based on the current model output, Argenica Therapeutics Limited appears to be undervalued with a upside of 27.00%.
Fair value vs market price — Argenica Therapeutics Limited (AGN)
Unlock premium access to view the live fair value comparison against current market price for AGN.
Frequently Asked Questions - AGN
How is AGN intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for AGN.
Is AGN undervalued or overvalued right now?
AGN is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for AGN: open their intrinsic value pages.